BiotechTube
Home/Precipio/Joe Silliman
JS

Joe Silliman

Chief Financial Officer

Precipio

Therapeutic Areas

OncologyHematology

Precipio Pipeline

DrugIndicationPhase
HemePath Diagnostic ServicesHematologic Malignancies (Leukemia, Lymphoma, Myeloma)Commercial
Solid Tumor Diagnostic ServicesSolid Tumors (Various Cancers)Commercial
Ice Cold CytologySpecimen Preservation for CytologyCommercial
IV-CellCell Culture for Hematologic MalignanciesResearch/Development

Leadership Team at Precipio

ID
Il Daniel
Chief Executive Officer
DC
Dr. Carlos A. Urmacher
Chief Medical Officer
DS
David S. Cohen
Chairman of the Board
JC
Jeffrey Cossman
Board Member
RP
Robert Patzig
Board Member
View full Precipio profile